Terms: = Leukemia AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874 AND Prognosis
206 results:
1. [Research Progress of Isocitrate Dehydrogenase Mutation-Positive Acute Myeloid leukemia --Review].
Ye F; Ma J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):630-633. PubMed ID: 38660877
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical Characteristics and prognosis of Acute Myeloid leukemia Patients with
Shan RQ; Huang S; Gu ZY; Wang N; Liu DH; Dou LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):327-334. PubMed ID: 38660832
[TBL] [Abstract] [Full Text] [Related]
3. Management of isocitrate dehydrogenase 1/2 mutated acute myeloid leukemia.
Fruchtman H; Avigan ZM; Waksal JA; Brennan N; Mascarenhas JO
Leukemia; 2024 May; 38(5):927-935. PubMed ID: 38600315
[TBL] [Abstract] [Full Text] [Related]
4. Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect.
Murdock HM; Ho VT; Garcia JS
Front Immunol; 2024; 15():1359113. PubMed ID: 38571944
[TBL] [Abstract] [Full Text] [Related]
5. Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML.
Shimony S; Bewersdorf JP; Shallis RM; Liu Y; Schaefer EJ; Zeidan AM; Goldberg AD; Stein EM; Marcucci G; Lindsley RC; Chen EC; Ramos Perez J; Stein A; DeAngelo DJ; Neuberg DS; Stone RM; Ball B; Stahl M
Leukemia; 2024 Apr; 38(4):762-768. PubMed ID: 38378841
[TBL] [Abstract] [Full Text] [Related]
6. Endogenous retroviruses Suppressyn and Syncytin-2 as innovative prognostic biomarkers in Acute Myeloid leukemia.
Shen J; Wen X; Xing X; Fozza C; Sechi LA
Front Cell Infect Microbiol; 2023; 13():1339673. PubMed ID: 38274728
[TBL] [Abstract] [Full Text] [Related]
7. A comparative safety review of targeted therapies for acute myeloid leukemia.
Dalgetty M; Leurinda C; Cortes J
Expert Opin Drug Saf; 2023; 22(12):1225-1236. PubMed ID: 38014918
[TBL] [Abstract] [Full Text] [Related]
8. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
9. Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition.
Giudice V; Serio B; Errichiello S; Ferrara I; Galdiero A; Bertolini A; Visconti R; De Novellis D; Guariglia R; Luponio S; Morini D; Della Corte AM; Sessa AM; Verdesca F; Langella M; Izzo B; Selleri C
Eur J Haematol; 2023 Nov; 111(5):729-741. PubMed ID: 37501402
[TBL] [Abstract] [Full Text] [Related]
10.
Babakhanlou R; DiNardo C; Borthakur G
Leuk Lymphoma; 2023; 64(11):1733-1741. PubMed ID: 37462435
[TBL] [Abstract] [Full Text] [Related]
11. Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.
Tefferi A; Alkhateeb H; Gangat N
Blood Cancer J; 2023 Jul; 13(1):108. PubMed ID: 37460550
[TBL] [Abstract] [Full Text] [Related]
12. [Efficacy and Safety of Decitabine Combined with Modified CAG Regimen in Patients Aged ≥ 70 Years with Newly Diagnosed Acute Myeloid leukemia].
Cao L; Jiang ZQ; Liu WJ; Sun Q; Zhu Y; Li JY; Qian SX; Hong M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):633-642. PubMed ID: 37356919
[TBL] [Abstract] [Full Text] [Related]
13. Identification and validation of a novel CD8+ T cell-associated prognostic model based on ferroptosis in acute myeloid leukemia.
Jiang G; Jin P; Xiao X; Shen J; Li R; Zhang Y; Li X; Xue K; Li J
Front Immunol; 2023; 14():1149513. PubMed ID: 37138885
[TBL] [Abstract] [Full Text] [Related]
14. Clinical characteristics and prognostic significance of DNA methylation regulatory gene mutations in acute myeloid leukemia.
Xu X; Wang H; Han H; Yao Y; Li X; Qi J; Cai C; Zhou M; Tang Y; Pan T; Zhang Z; Yang J; Wu D; Han Y
Clin Epigenetics; 2023 Mar; 15(1):54. PubMed ID: 36991512
[TBL] [Abstract] [Full Text] [Related]
15. [Analysis of epigenetic modification gene mutations among patients with acute myeloid leukemia].
Wei J; Qiu H; Zhou H; Chen Z; Miao L; Wang Y; Zhao L; Cai Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Apr; 40(4):435-441. PubMed ID: 36972938
[TBL] [Abstract] [Full Text] [Related]
16. Recent advances in targeted therapies in acute myeloid leukemia.
Bhansali RS; Pratz KW; Lai C
J Hematol Oncol; 2023 Mar; 16(1):29. PubMed ID: 36966300
[TBL] [Abstract] [Full Text] [Related]
17. Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors.
Aldea M; Tagliamento M; Bayle A; Vasseur D; Vergé V; Marinello A; Danlos FX; Blanc-Durand F; Bernard E; Cerbone L; Mosele MF; Renneville A; Hadoux J; Loriot Y; Sakkal M; Vozy A; Sarkozy C; Smolenschi C; Nicotra C; Martin-Romano P; Boccon-Gibod C; Habza W; Lazarovici J; Ponce S; Hollebecque A; Marzac C; Lacroix L; Barlesi F; André F; Besse B; Rouleau E; Italiano A; Micol JB
JCO Precis Oncol; 2023 Mar; 7():e2200583. PubMed ID: 36862966
[TBL] [Abstract] [Full Text] [Related]
18. Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.
Hosono N; Chi S; Yamauchi T; Fukushima K; Shibayama H; Katagiri S; Gotoh A; Eguchi M; Morishita T; Ogasawara R; Kondo T; Yanada M; Yamamoto K; Kobayashi T; Kuroda J; Usuki K; Utsu Y; Yoshimitsu M; Ishitsuka K; Ono T; Takahashi N; Iyama S; Kojima K; Nakamura Y; Fukuhara S; Izutsu K; Abutani H; Yamauchi N; Yuda J; Minami Y;
Cancer Sci; 2023 May; 114(5):2098-2108. PubMed ID: 36793248
[TBL] [Abstract] [Full Text] [Related]
19. Correlation of blood cell counts with mutant subtypes and impact prognosis in acute myeloid leukemia patients with FLT3 mutations.
Chen Y; Xie Y; Fang Y; Hong M; Shi J; Qian S
Hematology; 2023 Dec; 28(1):2172296. PubMed ID: 36738279
[TBL] [Abstract] [Full Text] [Related]
20. [Efficacy of venetoclax combined azacitidine in newly diagnosed acute myeloid leukemia unfit for standard chemotherapy: a single center experience].
Sun L; Ye SJ; Zhou N; Han XZ; Qi JX; Liu XJ; Luo JM; Yang L
Zhonghua Xue Ye Xue Za Zhi; 2022 Oct; 43(10):826-832. PubMed ID: 36709196
[No Abstract] [Full Text] [Related]
[Next]
